Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Validation of a predictive rule for the management of community-acquired pneumonia

A. Capelastegui, P. P. España, J. M. Quintana, I. Areitio, I. Gorordo, M. Egurrola, A. Bilbao
European Respiratory Journal 2006 27: 151-157; DOI: 10.1183/09031936.06.00062505
A. Capelastegui
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. P. España
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. M. Quintana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Areitio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Gorordo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Egurrola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Bilbao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • Fig. 1—
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1—

    Receiver-operating characteristic curves of predicting 30-day mortality according to pneumonia severity index (PSI), CURB-65 and CRB-65 (Confusion, Urea, Respiratory rate, Blood pressure, and age ≥65 yrs; see text for exact definition) score. ———: PSI (area under the curve (AUC) 0.888, 95% confidence interval (CI) 0.864–0.912); – – – –: CURB-65 (AUC 0.870, 95% CI 0.844–0.895); -------: CRB-65 (AUC 0.864, 95% CI 0.835–0.892).

Tables

  • Figures
  • Table 1—

    Characteristics of patients

    CharacteristicsInpatientsOutpatientsAll patients
    Subjects n11006761776
    Male715 (65)409 (60.5)1124 (63.3)
    Age yrs71.1±15.946.8±17.961.8±20.5
    Age ≥65 yrs823 (74.8)150 (22.2)973 (54.8)
    Nursing home resident99 (9.0)3 (0.4)102 (5.7)
    Prior antibiotics210 (19.8)126 (19.8)336 (19.8)
    Co-morbid illnesses
     Neoplastic disease70 (6.4)2 (0.3)72 (4.1)
     Liver disease55 (5.0)7 (1.0)62 (3.5)
     Congestive heart failure90 (8.2)11 (1.6)101 (5.7)
     Cerebrovascular disease135 (12.3)9 (1.3)144 (8.1)
     Renal disease106 (9.6)9 (1.3)115 (6.5)
    PSI risk class#
     I113 (10.3)407 (60.2)520 (29.3)
     II111 (10.1)176 (26)287 (16.2)
     III260 (23.6)78 (11.5)338 (19)
     IV423 (38.5)15 (2.2)438 (24.7)
     V193 (17.6)0 (0)193 (10.9)
    PSI98.8±35.546.6±21.278.9±39.9
    • Data presented as n (%) or mean±sd. #: severity of illness was assessed using the Pneumonia Severity Index (PSI) 6. Class I patients have the lowest severity and mortality risk, and class V the highest severity and mortality risk.

  • Table 2—

    Mortality, use of mechanical ventilation, and hospital admission according to CURB-65 and CRB-65 (Confusion, Urea, Respiratory rate, Blood pressure, and age ≥65 yrs) score

    Patients n30-day mortalityMechanical ventilation#Admission to hospital
    CURB-65 score
     06290 (0)0 (0)153 (24.3)
     13774 (1.1)2 (0.5)247 (65.5)
     247436 (7.6)9 (1.9)406 (85.7)
     322447 (21)4 (2)222 (99.1)
     46226 (41.9)2 (4.2)62 (100)
     5106 (60)1 (11.1)10 (100)
    Total1776119 (6.7)18 (1)1100 (61.9)
    p-value<0.001<0.001<0.001
    CRB-65 score
     07160 (0)1 (0.1)201 (28.1)
     168628 (4.1)8 (1.2)529 (77.1)
     229455 (18.7)6 (2.2)290 (98.6)
     36930 (43.5)2 (3.9)69 (100)
     4116 (54.6)1 (10)11 (100)
    Total1776119 (6.7)18 (1)1100 (61.9)
    p-value<0.001<0.001<0.001
    • Data presented as n (%) and included all patients (both inpatients and outpatients). #: deaths from pneumonia as an expected terminal event of a chronic disabling illness excluded.

  • Table 3—

    Additional criteria for admission decision in patients with CURB-65 (Confusion, Urea, Respiratory rate, Blood pressure, and age ≥65 yrs) scores of 0, 1, and 2

    CriteriaCURB-65 scoreTotalp-value
    012
    Outpatients and inpatients
     Patients n6293774741480
     Coexisting disease3.522.834.218.2<0.001
     Pa,O2 <60 mmHg7.528.742.424.1<0.001
     pH <7.351.81.14.62.5<0.01
     Bilateral or multilobe radiographic involvement9.214.121.114.3<0.001
     Pleural effusion68.2118.20.01
     One of previous criteria18.135.539.529.4<0.001
     Two or more criteria4.61832.917.1<0.001
    Inpatients
     Patients n153247406806
     Coexisting disease9.23036.229.2<0.001
     Pa,O2 <60 mmHg22.240.147.840.6<0.001
     pH <7.353.30.85.43.6<0.01
     Bilateral or multilobe radiographic involvement26.119.423.9230.25
     Pleural effusion17.79.711.812.30.06
     One of previous criteria43.142.541.141.90.89
     Two or more criteria16.326.337.430<0.001
    • Data are given as % unless otherwise indicated. Pa,O2: arterial oxygen tension. kPa = mmHg × 0.133.

  • Table 4—

    Distribution of CURB-65 (Confusion, Urea, Respiratory rate, Blood pressure, and age ≥65 yrs) scores according to the pneumonia severity index (PSI) and subgroup 30-day mortality

    CURB-65 scorePSI risk classTotalp-value
    I–IIIIV–V
    Patients nDied %Patients nDied %Patients nDied %
    0–19290.2772.610060.4<0.01
    21942.628011.14747.6<0.001
    >2224.627428.529626.70.01
    Total11450.763117.617766.7<0.001
    • Total patients includes both inpatients and outpatients.

  • Table 5—

    Inpatient medical indicators by CURB-65 (Confusion, Urea, Respiratory rate, Blood pressure, and age ≥65 yrs) scores

    Medical indicatorsCURB-65 scoreTotalp-value
    012345
    Patients n15324740622262101100
    Length of antibiotic therapy days#11.6±410.5±2.810.9±3.310.9±3.511.3±3.99.2±510.9±3.40.07
    Length of intravenous therapy mean days#2.6±2.22.6±2.42.9±2.73.3±3.74.9±4.85.6±4.62.9±2.9<0.001
    Mortality
     In-hospital mortality0 (0)3 (1.2)24 (5.9)42 (18.9)22 (35.5)5 (50)96 (8.7)<0.001
     30-day mortality0 (0)4 (1.6)35 (8.6)47 (21.2)26 (41.9)6 (60)118 (10.7)<0.001
    Mortality¶
     In-hospital mortality0 (0)3 (1.2)16 (4.1)23 (11.4)10 (20.8)4 (44.4)56 (5.3)<0.001
     30-day mortality0 (0)4 (1.6)24 (6.1)27 (13.4)12 (25)5 (55.6)72 (6.8)<0.001
    Admission to intensive care unit¶1 (0.7)8 (3.2)21 (5.3)11 (5.5)3 (6.3)1 (11.1)45 (4.3)0.12
    Mechanical ventilation¶0 (0)2 (0.8)9 (2.3)4 (2)2 (4.2)1 (11.1)18 (1.7)0.04
    30-day readmission1 (0.7)4 (1.6)14 (3.5)11 (5)3 (4.8)0 (0)33 (3)0.12
    Length of hospital stay#
     Days4.5±3.14.4±35.3±4.7)5.9±4.97±6.57±65.1±4.3<0.001
     Days median4445554<0.001
     ≤3 days65 (42.5)113 (46.3)153 (40.1)54 (30)9 (22.5)2 (40)396 (39.4)<0.01
    • Data are presented as mean±sd or n (%). #: in-hospital deaths excluded. ¶: deaths from pneumonia as an expected terminal event of a chronic disabling illness excluded.

PreviousNext
Back to top
View this article with LENS
Vol 27 Issue 1 Table of Contents
European Respiratory Journal: 27 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Validation of a predictive rule for the management of community-acquired pneumonia
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Validation of a predictive rule for the management of community-acquired pneumonia
A. Capelastegui, P. P. España, J. M. Quintana, I. Areitio, I. Gorordo, M. Egurrola, A. Bilbao
European Respiratory Journal Jan 2006, 27 (1) 151-157; DOI: 10.1183/09031936.06.00062505

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Validation of a predictive rule for the management of community-acquired pneumonia
A. Capelastegui, P. P. España, J. M. Quintana, I. Areitio, I. Gorordo, M. Egurrola, A. Bilbao
European Respiratory Journal Jan 2006, 27 (1) 151-157; DOI: 10.1183/09031936.06.00062505
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Determinants of community-acquired pneumonia in children and young adults in primary care
  • Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis
  • Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Show more Original Articles: Respiratory infections

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society